- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 230134, 4 pages
Neuropsychiatric Symptoms of Dementia: Consent, Quality of Life, and Dignity
Department of Psychiatry, Geriatric Psychiatry Program, University of British Columbia, c/o Mount Saint Joseph Hospital, Ward 1 South, 3080 Prince Edward Street, Vancouver, BC, Canada V5T 3N4
Received 2 April 2013; Revised 29 May 2013; Accepted 13 June 2013
Academic Editor: Patrick Kehoe
Copyright © 2013 Michael J. Passmore. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. G. Lyketsos, O. Lopez, B. Jones, A. L. Fitzpatrick, J. Breitner, and S. Dekosky, “Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study,” Journal of the American Medical Association, vol. 288, no. 12, pp. 1475–1483, 2002.
- S. L. Mitchell, D. K. Kiely, and M. B. Hamel, “Dying with advanced dementia in the nursing home,” Archives of Internal Medicine, vol. 164, no. 3, pp. 321–326, 2004.
- K. E. Mate, C. D. Pond, P. J. Magin, et al., “Diagnosis and disclosure of a memory problem is associated with quality of life in community based older Australians with dementia,” International Psychogeriatrics, vol. 24, no. 12, pp. 1962–1971, 2012.
- D. B. Hogan, P. Bailey, and S. Black, “Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia,” Canadian Medical Association Journal, vol. 179, no. 8, pp. 787–793, 2008.
- J. Phillips, C. D. Pond, N. E. Paterson, et al., “Difficulties in disclosing the diagnosis of dementia: a qualitative study in general practice,” British Journal of General Practice, vol. 62, pp. e546–e553, 2012.
- V. Moore and S. Cahill, “Diagnosis and disclosure of dementia-a comparative qualitative study of Irish and Swedish General Practitioners,” Aging & Mental Health, vol. 17, no. 1, pp. 77–84, 2013.
- J. Kai, J. Beavan, and C. Faull, “Challenges of mediated communication, disclosure and patient autonomy in cross-cultural cancer care,” British Journal of Cancer, vol. 105, no. 7, pp. 918–924, 2011.
- O. Karnieli-Miller, P. Werner, J. Aharon-Peretz, et al., “Expectations, experiences, and tensions in the memory clinic: the process of diagnosis disclosure of dementia within a triad,” International Psychogeriatrics, vol. 24, no. 11, pp. 1756–1770, 2012.
- M. von Kutzleben, W. Schmid, M. Halek, B. Holle, and S. Bartholomeyczik, “Community-dwelling persons with dementia: what do they need? What do they demand? What do they do? A systematic review on the subjective experiences of persons with dementia,” Aging and Mental Health, vol. 16, no. 3, pp. 378–390, 2012.
- B. D. Carpenter, C. Xiong, E. K. Porensky et al., “Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment,” Journal of the American Geriatrics Society, vol. 56, no. 3, pp. 405–412, 2008.
- L. Lee and W. W. Weston, “Disclosing a diagnosis of dementia: helping learners to break bad news,” Canadian Family Physician, vol. 57, no. 7, pp. e851–e852, 2011.
- J. A. Billings and E. L. Krakauer, “On patient autonomy and physician responsibility in end-of-life care,” Archives of Internal Medicine, vol. 171, no. 9, pp. 849–853, 2011.
- S. Banerjee, “The use of antipsychotic medication for people with dementia: Time for action,” UK Department of Health, 2009, http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108302.pdf.
- K. F. Huybrechts, K. J. Rothman, R. A. Silliman, M. A. Brookhart, and S. Schneeweiss, “Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes,” Canadian Medical Association Journal, vol. 183, no. 7, pp. E411–E419, 2011.
- C. Ballard, M. L. Hanney, M. Theodoulou et al., “The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial,” The Lancet Neurology, vol. 8, no. 2, pp. 151–157, 2009.
- L. S. Schneider, P. N. Tariot, K. S. Dagerman et al., “Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease,” New England Journal of Medicine, vol. 355, no. 15, pp. 1525–1538, 2006.
- P. Naarding, M. Van Grevenstein, and A. T. F. Beekman, “Benefit-risk analysis for the clinician: “primum non nocere” revisited—the case for antipsychotics in the treatment of behavioural disturbances in dementia,” International Journal of Geriatric Psychiatry, vol. 25, no. 5, pp. 437–440, 2010.
- J. van de Ven-Vakhteeva, H. Bor, R. B. Wetzels, et al., “The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes,” International Journal of Geriatric Psychiatry, vol. 28, no. 5, pp. 530–538, 2013.
- C. Ballard, M. M. Lana, M. Theodoulou et al., “A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial),” PLoS Medicine, vol. 5, no. 4, Article ID e76, pp. 587–599, 2008.
- D. P. Devanand, G. H. Pelton, K. Cunqueiro, H. A. Sackeim, and K. Marder, “A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease,” International Journal of Geriatric Psychiatry, vol. 26, no. 9, pp. 937–943, 2011.
- D. P. Devanand, J. Mintzer, S. K. Schultz, et al., “Relapse risk after discontinuation of risperidone in Alzheimer's disease,” The New England Journal of Medicine, vol. 367, pp. 1497–1507, 2012.
- B. S. Husebo, C. Ballard, R. Sandvik, O. B. Nilsen, and D. Aarsland, “Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial,” British Medical Journal, vol. 343, p. d4065, 2011.
- J. Simard and L. Volicer, “Effects of namaste care on residents who do not benefit from usual activities,” American Journal of Alzheimer's Disease and other Dementias, vol. 25, no. 1, pp. 46–50, 2010.
- “Providence Health Care-Palliative Care Service Team. Vancouver BC,” 2011.
- C. Parsons, C. M. Hughes, A. P. Passmore, and K. L. Lapane, “Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?” Drugs and Aging, vol. 27, no. 6, pp. 435–449, 2010.
- L. Volicer, “Goals of care in advanced dementia: quality of life, dignity and comfort,” Journal of Nutrition, Health and Aging, vol. 11, no. 6, p. 481, 2007.
- L. Volicer and L. Bloom-Charette, Enhancing the Quality of Life in Advanced Dementia, Taylor & Francis, Philadelphia, Pa, USA, 1999.
- J. Fook and A. Kellehear, “Using critical reflection to support health promotion goals in palliative care,” Journal of Palliative Care, vol. 26, no. 4, pp. 295–302, 2010.
- “MyVoice-Advance care planning guide. BC Ministry of Health,” 2012, http://www.health.gov.bc.ca/library/publications/year/2013/MyVoice-AdvanceCarePlanningGuide.pdf.